Increased insulin resistance following switch from efavirenz to cobicistat-boosted elvitegravir.
Saved in:
| Title: | Increased insulin resistance following switch from efavirenz to cobicistat-boosted elvitegravir. |
|---|---|
| Authors: | Pickering RT; Boston University School of Medicine, Boston, MA, USA.; Boston Medical Center, Boston, MA, USA., Asundi A; Boston University School of Medicine, Boston, MA, USA.; Boston Medical Center, Boston, MA, USA., Olson A; Boston University School of Medicine, Boston, MA, USA., Soden K; Boston Medical Center, Boston, MA, USA., Kuritzkes DR; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Lin NH; Boston University School of Medicine, Boston, MA, USA.; Boston Medical Center, Boston, MA, USA. |
| Source: | Antiviral therapy [Antivir Ther] 2025 Feb; Vol. 30 (1), pp. 13596535251314571. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print Cited Medium: Internet ISSN: 2040-2058 (Electronic) Linking ISSN: 13596535 NLM ISO Abbreviation: Antivir Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
